F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway
2024

F13B's Role in Liver Cancer Progression

Sample size: 371 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jiang Dong, Qi Zhi, Xu Zhi-ying, Li Yi-ran

Primary Institution: Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, China

Hypothesis

F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway.

Conclusion

F13B is a significant prognostic factor in hepatocellular carcinoma and may serve as a therapeutic target.

Supporting Evidence

  • F13B expression was notably reduced in HCC cell lines and tissues.
  • Overexpression of F13B inhibited cell invasion, migration, and proliferation.
  • F13B negatively regulates VEGFA expression, affecting endothelial cell proliferation.
  • F13B overexpression reversed VEGF-induced upregulation of angiogenesis markers.
  • F13B plays a crucial role in HCC progression through the HIF-1α/VEGF pathway.

Takeaway

F13B is a gene that helps control how cancer grows in the liver, and scientists think it could be a good target for new treatments.

Methodology

The study used bioinformatics analysis and in vitro experiments to investigate F13B's role in HCC.

Limitations

The study's retrospective nature and reliance on public databases limited direct patient sample analysis.

Participant Demographics

The study analyzed data from 371 primary tumor tissues and 50 normal liver tissues.

Statistical Information

P-Value

0.00246

Confidence Interval

95% CI: 0.79781–0.953

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.17305/bb.2024.10794

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication